Macy's Inc
Change company Symbol lookup
Select an option...
M Macy's Inc
BAC Bank of America Corp
GSPH Geospatial Corp
SLV iShares Silver Trust
STOR Store Capital Corp
GLU Gabelli Global Utility & Income Trust
XLB Materials Select Sector SPDR® Fund
XLF Financial Select Sector SPDR® Fund
XLE Energy Select Sector SPDR® Fund
HSBC-A HSBC Holdings PLC
Go

Consumer Discretionary : Multiline Retail | Mid Cap ValueCompany profile

Macy's, Inc. is an omnichannel retail company operating stores, Websites and mobile applications under various brands, such as Macy's, Bloomingdale's and Bluemercury. The Company sells a range of merchandise, including apparel and accessories (men's, women's and children's), cosmetics, home furnishings and other consumer goods. Its subsidiaries provide various support functions to its retail operations. Its bank subsidiary, FDS Bank, provides credit processing, certain collections, customer service and credit marketing services in respect of all credit card accounts that are owned either by Department Stores National Bank (DSNB), which is a subsidiary of Citibank N.A., or FDS Bank. The private label brands offered by the Company include Alfani, American Rag, Aqua, Bar III, Belgique, Charter Club, Club Room, Epic Threads, first impressions, Giani Bernini, Greg Norman for Tasso Elba, Holiday Lane, Home Design, Hotel Collection, John Ashford, Karen Scott, Thalia Sodi and lune+aster.

Closing Price
$25.79
Day's Change
1.04 (4.20%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.99
Day's Low
24.86
Volume
(Average)
Volume:
14,089,412

10-day average volume:
14,625,675
14,089,412

Valens GroWorks a rare gainer in cannabis sector after inking extraction deal with Canopy Growth

1:51 pm ET December 13, 2018 (MarketWatch)
Print

Canada's Valens GroWorks Corp. shares were a standout in a mostly lower cannabis sector on Thursday, climbing 6% after news of an extraction agreement with Canopy Growth Corp. (WEED.T). Under the terms of the multi-year deal, Valens will use its proprietary technology to process whole flower and trim into high-grade cannabis resin for Canopy. The first shipment for processing is expected to arrive by year-end. Valens is expecting to have its first batch of branded products available through Canopy's sales channels for medical and recreational cannabis by the end of March 2019. Valens shares are up 32% in the month to date, while the S&P 500 has fallen 4%. Canopy shares were down 4% Thursday, and have fallen about 9% in the month to date.

-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

December 13, 2018 13:51 ET (18:51 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.